Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03197532 · ClinicalTrials.gov registry record
Assessing Urinary Hormones in Female Cancer Survivors
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 38
- Enrollment target
NCT03197532: Completed study, sponsored by University of Pennsylvania.
NCT03197532 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03197532 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
Study Summary
Women of late to mid reproductive age may participate in a study using novel methodology to identify subtle changes in the reproductive endocrine axis via daily urine hormone analysis, which may have important implications for reproduction and may signal reproductive senescence.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2011-01 |
| Est. Completion | 2016-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03197532
The ClinicalTrials.gov registry entry for NCT03197532 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03197532 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03197532 about?
NCT03197532 is a clinical study titled "Assessing Urinary Hormones in Female Cancer Survivors". Women of late to mid reproductive age may participate in a study using novel methodology to identify subtle changes in the reproductive endocrine axis via daily urine hormone analysis, which may have important implications for reproduction and may signal reproductive senescence.
What is the current status of trial NCT03197532?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2011-01. Estimated completion is 2016-05.
Who is sponsoring clinical trial NCT03197532?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.